HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH
Q61K MUTATION
US Application 63/177,570
Filed on 2021-04-21
Filed on 2021-04-21
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH
High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors
US Application 62/924,498
Filed on 2019-10-22
Filed on 2019-10-22
RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER
US Application 62/900,240
Filed on 2019-09-13
Filed on 2019-09-13
INHIBITORS OF HISTONE DEMETHYLASES
US Application 62/936,722
Filed on 2019-11-18
Filed on 2019-11-18
METHODS OF TREATING DIFFUSE LARGE B CELL LYMPHOMA BASED ON PARTICULAR GENETIC SUBTYPE
US Application 62/981,382
Filed on 2020-02-25
Filed on 2020-02-25
Chimeric Antigen Receptors Containing Glypican 2 Binding Domains
US Application 62/876,483
Filed on 2019-07-19
Filed on 2019-07-19
A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA
US Application 62/914,138
Filed on 2019-10-11
Filed on 2019-10-11
PEGYLATED RECOMBINANT IMMUNOTOXINS
US Application 62/935,822
Filed on 2019-11-15
Filed on 2019-11-15
HUMAN IMMUNOGENIC EPITOPES OF H, K, AND E HUMAN ENDOGENOUS RETROVIRUSES (HERVs)
US Application 62/963,856
Filed on 2020-01-21
Filed on 2020-01-21
HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVs)
US Application 62/963,872
Filed on 2020-01-21
Filed on 2020-01-21